These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2310251)

  • 21. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass.
    Tuman KJ; Spiess BD; McCarthy RJ; Ivankovich AD
    Anesth Analg; 1989 Jul; 69(1):69-75. PubMed ID: 2742171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery.
    Szalados JE; Ouriel K; Shapiro JR
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):515-8. PubMed ID: 7803739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reevaluation of heparin requirements for cardiopulmonary bypass.
    Cardoso PF; Yamazaki F; Keshavjee S; Schaefers HJ; Hsieh CM; Wang LS; Glynn MF; Patterson GA; Cooper JD
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):153-60. PubMed ID: 1986159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
    Huyzen RJ; Harder MP; Huet RC; Boonstra PW; Brenken U; van Oeveren W
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculating the protamine-heparin reversal ratio: a pilot study investigating a new method.
    Wright SJ; Murray WB; Hampton WA; Hargovan H
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):416-21. PubMed ID: 8400096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in heparin potency and effects on the activated clotting time in children undergoing cardiopulmonary bypass.
    Guzzetta NA; Amin SJ; Tosone AK; Miller BE
    Anesth Analg; 2012 Oct; 115(4):921-4. PubMed ID: 22822188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of activated clotting time to monitor anticoagulation during cardiac surgery.
    Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV
    Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.
    Najman DM; Walenga JM; Fareed J; Pifarré R
    Ann Thorac Surg; 1993 Mar; 55(3):662-6. PubMed ID: 7680854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE; Shupak RC; Pontius J; Rao AK
    Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
    Niles SD; Sutton RG; Ploessl J; Pennell B
    J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations.
    Mattox KL; Guinn GA; Rubio PA; Beall AC
    Ann Thorac Surg; 1975 Jun; 19(6):634-8. PubMed ID: 1079715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation.
    Hashimoto K; Yamagishi M; Sasaki T; Nakano M; Kurosawa H
    Ann Thorac Surg; 1994 Sep; 58(3):799-804; discussion 804-5. PubMed ID: 7944706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.